A retrospective database analysis of patients with chronic hepatitis C virus (HCV) infection who were administered elbasvir/grazoprevir (ZEPATIER) in the US Department of Veterans Affairs (VA) healthcare system
Phase of Trial: Phase IV
Latest Information Update: 26 Apr 2017
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 26 Apr 2017 New trial record
- 21 Apr 2017 Results from this trial were presented at the The International Liver Congress 2017, according to a Merck and Co. media release.
- 21 Apr 2017 Results published in a Merck and Co. media release.